HIGHLIGHTS
- who: Alessandro Gambella from the Department of Medical Sciences, University of Turin, Turin, Italy have published the paper: HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet, in the Journal: (JOURNAL)
- what: This study aims to evaluate the expression and prognostic potential in a series of stage II/III CRCs. expression was evaluated in 100 pT3 CRC cases by means of immunohistochemistry using the 4H84 and MEM-G/2 monoclonal antibodies. The study has however underlined problems in the evaluation of HLA-G by immunohistochemistry regarding which antibody . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.